within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BJ06_Semaglutide;

model Semaglutide_1
  extends Pharmacolibrary.Drugs.ATC.A.A10BJ06_1;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A10BJ06_1</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for the treatment of type 2 diabetes mellitus and chronic weight management. It is currently approved for clinical use in both oral and subcutaneous injectable formulations.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy subjects after oral administration of semaglutide tablets.</p><h4>References</h4><ol><li><p>Overgaard, RV, et al., &amp; Kildemoes, RJ (2021). Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials. <i>Clinical pharmacokinetics</i> 60(10) 1335–1348. DOI:<a href=&quot;https://doi.org/10.1007/s40262-021-01025-x&quot;>10.1007/s40262-021-01025-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33969456/&quot;>https://pubmed.ncbi.nlm.nih.gov/33969456</a></p></li><li><p>Granhall, C, et al., &amp; Anderson, TW (2018). Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment. <i>Clinical pharmacokinetics</i> 57(12) 1571–1580. DOI:<a href=&quot;https://doi.org/10.1007/s40262-018-0649-2&quot;>10.1007/s40262-018-0649-2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29623579/&quot;>https://pubmed.ncbi.nlm.nih.gov/29623579</a></p></li><li><p>Yang, XD, &amp; Yang, YY (2024). Clinical Pharmacokinetics of Semaglutide: A Systematic Review. <i>Drug design, development and therapy</i> 18 2555–2570. DOI:<a href=&quot;https://doi.org/10.2147/DDDT.S470826&quot;>10.2147/DDDT.S470826</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38952487/&quot;>https://pubmed.ncbi.nlm.nih.gov/38952487</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Semaglutide_1;
